Authors/Disclosures
|
Randolph S. Marshall, MD, FAAN
(Columbia University)
|
The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |
|
Joanne Festa, PhD
(Neurological Institute)
|
No disclosure on file |
|
Adam De Havenon, MD, FAAN
(Yale University)
|
Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Colin Derdeyn, MD
(University of Iowa Hospitals & Clinics)
|
The institution of Dr. Derdeyn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. The institution of Dr. Derdeyn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNO. The institution of Dr. Derdeyn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silk Road. Dr. Derdeyn has stock in Pulse Therapeutics. Dr. Derdeyn has received publishing royalties from a publication relating to health care. |
|
MaryKay A. Pavol, PhD
(Neurological Institute)
|
Dr. Pavol has nothing to disclose. |
|
William R. Clarke, PhD
(The University of Iowa)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Harold P. Adams, Jr., MD, FAAN
(University of Iowa Hospitals)
|
The institution of Dr. Adams has received research support from NINDS. |
|
William J. Powers, MD, FAAN
(Duke University School of Medicine)
|
Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to AAN interests or activities. |
|
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN
(University of Alabama At Birmingham)
|
Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care. |